// App-Quantinova.ai

: Plasma Exchange for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy: Implications for Clinical Care and Clinical Trial Design

Researchers

Presenter

  • Vinay K. Giri

Principal Investigators

  • Muharrem Yunce

  • Srikanth Muppidi

  • Kavitha J. Ramchandran

  • Tamiko R. Katsumoto

  • Beth A Martin-Kool

Medical Centers

  • Department of Medicine, Division of Rheumatology, Stanford University School of Medicine, Stanford, CA

  • Department of Medicine, Division of Hematology, Stanford, Stanford, CA

  • Department of Medicine, Stanford University School of Medicine, Stanford, CA

  • Department of Pathology, Division of Transfusion Medicine, Stanford University School of Medicine, Stanford, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Central Nervous System (CNS)

  • Peripheral Nervous System

  • Genetic Disorder

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Inflammatory demyelinating polyneuropathy

  • Thrombotic thrombocytopenic purpura

  • Hemophagocytic lymphohistiocytosis

  • Cutaneous squamous cell carcinoma

  • Squamous cell carcinoma

  • Deep vein thrombosis

  • Arrhythmia

  • Myasthenia gravis

  • Venous thrombosis

  • Thrombocytopenia

  • Thymomas

  • Peripheral neuropathy

  • Viral myocarditis

  • Solid malignancies

  • Myositis

  • Sarcoma

Biomarkers

  • Aspartate aminotransferase

  • Alanine transaminase

  • Creatinine

  • Fibrinogen

  • Human albumin

  • Serpin B3

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Dextrose Intravenous

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Natalizumab

  • Envafolimab

  • Durvalumab

  • Enoxaparin

  • Enoxaparin sodium

  • Fibrinogen (IV)

  • Nivolumab

  • Anakinra

  • Heparin

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved